Professional antigen-presenting cells (APC) such as monocytes and dendritic
cells (DC) bearing high-affinity IgE receptors (Fc epsilon RI) efficiently
present IgE-bound antigens to T cells. Fc epsilon RI expression is upregul
ated on APC from atopic donors, especially in inflamed tissues. These data
suggest a pathophysiological concept of an IgE-mediated delayed-type hypers
ensitivity reaction in atopic diseases. However, FceRI ligation also leads
to the synthesis of proinflammatory cytokines and other molecules involved
in inflammatory reactions. The investigation of transcription factors media
ting these effects has only recently commenced. In general, members of the
NF-KB family are known to regulate APC function and differentiation, with t
he RelB subunit being especially important in DC generation. In addition, I
karos and PU.1 have also been shown to be essential factors for DC differen
tiation, whereas Oct-2 is upregulated by differentiation towards macrophage
s. Recently, Fc epsilon RI has been demonstrated to induce NF-KB activation
via I kappaB-alpha serine phosphorylation and degradation in monocytes and
DC. Inhibitors of NF-kappaB activation such as N-acetylcysteine or N-tosyl
-L-phenylalanine chloromethyl ketone can suppress Fc epsilon RI-induced TNF
-alpha and MCP-1 release. Interestingly, in human epidermal Langerhans' cel
ls (LC), NF-kappaB activation can only be observed when large amounts of Fc
epsilon RI are present. In addition, the composition of NF-kappaB complexe
s differs between monocytes, monocyte-derived DC and LC, suggesting a cell
type-specific regulation. Moreover, the transcription factor NFAT is induce
d upon Fc epsilon RI ligation in human APC, The elucidation of further tran
scription factors involved in Fc epsilon RI signaling in APC should contrib
ute to the employment of new inhibition strategies for the treatment of ato
pic and other inflammatory diseases.